Method development and validation for simultaneous determination of six tyrosine kinase inhibitors and two active metabolites in human plasma/serum using UPLC–MS/MS for therapeutic drug monitoringMenghua Zhang, Liyan Miao, Shenhao Jiang et al.|Journal of Pharmaceutical and Biomedical Analysis|2021Cited by 18
The Correlation Between Busulfan Exposure and Clinical Outcomes in Chinese Pediatric Patients: A Population Pharmacokinetic StudyXiaohuan Du, Liyan Miao, Chenrong Huang et al.|Frontiers in Pharmacology|2022Cited by 6
Study of genetic polymorphisms and steady-state trough concentrations of imatinib and its active metabolite in predicting efficacy in gastrointestinal stromal tumorsMenghua Zhang, Liyan Miao, Zhiyao Chen et al.|Frontiers in Pharmacology|2025Cited by 1
Method Development and Validation for Simultaneous Determination of Six Tyrosine Kinase Inhibitors and Two Active Metabolites in Human Plasma Using UPLC–MS/MS for Therapeutic Drug MonitoringMenghua Zhang, Liyan Miao, Min Tao et al.|SSRN Electronic Journal|2021Cited by 0